Exploiting pre-existing CD4(+) T cell help from BCG vaccination to improve anti-viral antibody responses

The continuing emergence of viral pathogens and their rapid spread into heavily populated areas around the world underscore the urgency for development of highly effective vaccines to generate protective anti-viral antibody responses. Many established and newly emerging viral pathogens, including HI...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Immunol
Main Authors: Ng, Tony W., Wirchnianski, Ariel S., Wec, Anna Z., Fels, J. Maximilian, Johndrow, Christopher T., Saunders, Kevin O., Liao, Hua-Xin, Chan, John, Jacobs, William R., Chandran, Kartik, Porcelli, Steven A.
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7343599/
https://ncbi.nlm.nih.gov/pubmed/32513849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.2000191
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares